Healthcare provider profile · identity verified

Tracy Todd Smith, M.D.

Internal Medicine · PRESCOTT, AZ · NPI 1821067448

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	724	267
Levothyroxine Sodium	Levothyroxine Sodium	598	214
Amlodipine Besylate	Amlodipine Besylate	444	151
Lisinopril	Lisinopril	390	139
Losartan Potassium	Losartan Potassium	355	129
Rosuvastatin Calcium	Rosuvastatin Calcium	295	114
Simvastatin	Simvastatin	215	79
Tamsulosin Hcl	Tamsulosin Hcl	204	80
Pantoprazole Sodium	Pantoprazole Sodium	195	67
Metformin Hcl	Metformin Hcl	187	73
Omeprazole	Omeprazole	175	71
Metoprolol Succinate	Metoprolol Succinate	163	53
Alendronate Sodium	Alendronate Sodium	158	50
Gabapentin	Gabapentin	153	61
Montelukast Sodium	Montelukast Sodium	128	50
Escitalopram Oxalate	Escitalopram Oxalate	119	36
Synthroid	Levothyroxine Sodium	118	43
Metoprolol Tartrate	Metoprolol Tartrate	114	42
Allopurinol	Allopurinol	106	45
Hydrochlorothiazide	Hydrochlorothiazide	93	41
Clopidogrel	Clopidogrel Bisulfate	87	31
Sertraline Hcl	Sertraline Hcl	87	31
Carvedilol	Carvedilol	85	29
Potassium Chloride	Potassium Chloride	85	39
Prednisone	Prednisone	75	50
Zolpidem Tartrate	Zolpidem Tartrate	74	29
Trazodone Hcl	Trazodone Hcl	68	27
Citalopram Hbr	Citalopram Hydrobromide	67	24
Eliquis	Apixaban	67	24
Finasteride	Finasteride	66	25
Ezetimibe	Ezetimibe	64	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	64	23
Meloxicam	Meloxicam	63	27
Memantine Hcl	Memantine Hcl	59	suppressed
Benazepril Hcl	Benazepril Hcl	53	17
Bupropion Xl	Bupropion Hcl	49	20
Spironolactone	Spironolactone	48	25
Albuterol Sulfate Hfa	Albuterol Sulfate	45	30
Famotidine	Famotidine	45	19
Januvia	Sitagliptin Phosphate	45	11
Ozempic	Semaglutide	45	suppressed
Alprazolam	Alprazolam	44	16
Atenolol	Atenolol	44	17
Fluoxetine Hcl	Fluoxetine Hcl	43	15
Metformin Hcl Er	Metformin Hcl	43	17
Pravastatin Sodium	Pravastatin Sodium	43	17
Azithromycin	Azithromycin	41	37
Valsartan	Valsartan	40	18
Tramadol Hcl	Tramadol Hcl	39	suppressed
Terazosin Hcl	Terazosin Hcl	38	11
Glipizide Er	Glipizide	37	15
Jardiance	Empagliflozin	36	suppressed
Estradiol	Estradiol	34	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	14
Valacyclovir	Valacyclovir Hcl	32	13
Lovastatin	Lovastatin	29	11
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	11
Myrbetriq	Mirabegron	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	21
Xarelto	Rivaroxaban	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	11
Glimepiride	Glimepiride	27	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	12
Glipizide	Glipizide	25	14
Irbesartan	Irbesartan	25	suppressed
Celecoxib	Celecoxib	24	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	11
Acyclovir	Acyclovir	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	14
Propranolol Hcl	Propranolol Hcl	21	suppressed
Lorazepam	Lorazepam	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Furosemide	Furosemide	19	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	11
Torsemide	Torsemide	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Temazepam	Temazepam	17	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Cephalexin	Cephalexin	14	suppressed
Diazepam	Diazepam	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Baclofen	Baclofen	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Novolog	Insulin Aspart	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error